MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
143 hedge funds and large institutions have $770M invested in Momenta Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-5
Holders Change %
-3.38%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
66
Reduced
30
Closed
24
Calls
$5.99M
Puts
$1.14M
Net Calls
+$4.85M
Net Calls Change
+$1.73M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$56.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.8M |
| 3 |
VAM
Visium Asset Management
New York
|
+$9.12M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$5.38M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.34M |
Top Sellers
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$30.1M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$14.6M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$10.9M |
| 4 |
Citigroup
New York
|
-$5.87M |
| 5 |
Morgan Stanley
New York
|
-$5.63M |
